Allogene Therapeutics, Inc. (ALLO) Operating margin 2021–2024
Allogene Therapeutics, Inc. (ALLO) operating margin by fiscal year — reported operating income divided by reported revenue.
-1241813.6%FY2024 · since FY2021: -157.9% → -1241813.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -1241813.6% | -896827.3 pp |
| FY2023 | -344986.3% | -129899.1 pp |
| FY2022 | -215087.2% | -214929.2 pp |
| FY2021 | -157.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice